Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.
Asmuth DM, Murphy RL, Rosenkranz SL, Lertora JJ, Kottilil S, Cramer Y, Chan ES, Schooley RT, Rinaldo CR, Thielman N, Li XD, Wahl SM, Shore J, Janik J, Lempicki RA, Simpson Y, Pollard RB; AIDS Clinical Trials Group A5192 Team.
Asmuth DM, et al. Among authors: rosenkranz sl.
J Infect Dis. 2010 Jun 1;201(11):1686-96. doi: 10.1086/652420.
J Infect Dis. 2010.
PMID: 20420510
Free PMC article.
Clinical Trial.